Short-term and long-term effect of a DANish hospital based comprehensive cardiac REHABilitation programme (The DANREHAB study)

ISRCTN ISRCTN74601515
DOI https://doi.org/10.1186/ISRCTN74601515
Protocol serial number N/A
Sponsor The Danish Heart Foundation
Funders The Danish Heart Foundation, A full list of all sources of funding can be accessed at http://www.cardiacrehabilitation.dk/Sponsors.172.0.html
Submission date
23/01/2004
Registration date
09/03/2004
Last edited
21/09/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mrs Ann-Dorthe Zwisler
Scientific

National Institute of Public Health
Copenhagen OE
DK2100
Denmark

Phone +45 3920 7777
Email ado@niph.dk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Scientific titleShort-term and long-term effect of a DANish hospital based comprehensive cardiac REHABilitation programme (The DANREHAB study): a randomized clinical trial
Study acronymDANREHAB
Study objectivesThe DANish Cardiac ReHABilitation (DANREHAB) trial was designed as a centrally randomized clinical trial to clarify whether hospital-based comprehensive cardiac rehabilitation is superior to usual care for patients with congestive heart failure, ischemic heart disease, or high risk for ischemic heart disease.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedComprehensive cardiac rehabilitation
InterventionHospital-based phase II comprehensive cardiac rehabilitation (CR) versus usual care. The CR was an individually tailored, multidisciplinary program (6 weeks of intensive CR and 12 months of follow-up) including patient education, exercise training, dietary counseling, smoking cessation, psychosocial support, risk factor management, and clinical assessment.
Intervention typeOther
Primary outcome measure(s)

A combined primary outcome measure included total mortality, myocardial infarction, or readmissions due to heart disease based on linkage to public registries.

Key secondary outcome measure(s)

Not provided at time of registration

Completion date01/03/2003

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration770
Key inclusion criteriaPatients discharged from a Department of Cardiology with patients with congestive heart failure, ischemic heart disease, or high risk for ischemic heart disease.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/12/1999
Date of final enrolment01/03/2003

Locations

Countries of recruitment

  • Denmark

Study participating centre

National Institute of Public Health
Copenhagen OE
DK2100
Denmark

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2005 Yes No
Study website Study website 11/11/2025 11/11/2025 No Yes

Editorial Notes

21/09/2017: internal review.